Vor Biopharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vor Biopharma and other ETFs, options, and stocks.

About VOR

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies.

CEO

Bob Ang

CEOBob Ang

Employees

159

Employees159

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2015

Founded2015

Employees

159

Employees159

VOR Key Statistics

Market cap

21.32M

Market cap21.32M

Price-Earnings ratio

-0.10

Price-Earnings ratio-0.10

Dividend yield

—

Dividend yield—

Average volume

3.96M

Average volume3.96M

High today

$0.18

High today$0.18

Low today

$0.1535

Low today$0.1535

Open price

$0.1619

Open price$0.1619

Volume

4.60M

Volume4.60M

52 Week high

$1.87

52 Week high$1.87

52 Week low

$0.1311

52 Week low$0.1311

Analyst ratings

100%

of 6 ratings

Buy

Hold

100%

Sell

People also own

Based on the portfolios of people who own VOR. This list is generated using Robinhood data, and it’s not a recommendation.

Vor Biopharma

Why Robinhood?

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. Show more

VOR Key Statistics

Analyst ratings

100%

People also own

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies.